PTJ
BMY icon

Paul Tudor Jones’s Bristol-Myers Squibb BMY Stock Holding History

Paul Tudor Jones’s Portfolio BMY Stock Details BMY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$4.33M Sell
75,100
-146,700
-66% -$8.42M 0.01% 1385
2026
Q1 		$13.5M Buy
221,800
+13,200
+6% +$769K 0.03% 596
2025
Q4 		$11.3M Buy
208,600
+175,900
+538% +$8.46M 0.02% 665
2025
Q3 		$1.47M Sell
32,700
-106,500
-77% -$4.97M ﹤0.01% 2004
2025
Q2 		$6.44M Buy
+139,200
New +$6.83M 0.01% 934
2025
Q1 		– Sell
-12,300
Closed -$696K – 3078
2024
Q4 		$696K Sell
12,300
-492,200
-98% -$27.5M ﹤0.01% 1999
2024
Q3 		$26.1M Sell
504,500
-498,600
-50% -$23.4M 0.1% 118
2024
Q2 		$41.7M Buy
1,003,100
+676,700
+207% +$30.3M 0.21% 48
2024
Q1 		$17.7M Sell
326,400
-296,600
-48% -$15.1M 0.11% 165
2023
Q4 		$32M Buy
623,000
+557,900
+857% +$29.3M 0.26% 36
2023
Q3 		$3.78M Buy
65,100
+4,900
+8% +$300K 0.04% 627
2023
Q2 		$3.85M Buy
+60,200
New +$4.04M 0.05% 555
2022
Q3 		– Sell
-5,500
Closed -$424K – 2314
2022
Q2 		$424K Buy
+5,500
New +$419K 0.01% 1359
2022
Q1 		– Sell
-28,300
Closed -$1.76M – 2035
2021
Q4 		$1.76M Buy
28,300
+20,800
+277% +$1.22M 0.03% 697
2021
Q3 		$446K Buy
+7,500
New +$494K 0.01% 1734

Other funds holding BMY

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Paul Tudor Jones's BMY Position: Q1 2026 in Review

Paul Tudor Jones sold out of Bristol-Myers Squibb (BMY) in Q1 2026, closing a stake of 33,595 shares — an estimated $1.96M sold.

Paul Tudor Jones first reported a position in BMY in Q3 2013 and held it in 37 quarters. The position peaked at $83.1M in Q2 2024. 2,532 funds tracked by Wall St. Rank hold BMY as of Q1 2026.

  • Paul Tudor Jones reported no remaining Bristol-Myers Squibb position as of Q1 2026 after selling out during the quarter.
  • Paul Tudor Jones sold 33,595 Bristol-Myers Squibb shares in Q1 2026, an estimated $1.96M.
  • Paul Tudor Jones first reported a position in Bristol-Myers Squibb in Q3 2013 and held it in 37 quarters.
  • Paul Tudor Jones's Bristol-Myers Squibb position peaked at $83.1M in Q2 2024.
  • 2,532 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q1 2026.

Based on Tudor Investment Corp's 13F filing for Q1 2026, filed 15 May 2026.